Last updated: 2026-09-16 09:46:20. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
BioHarvest Sciences Inc. (BHST) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $1.79, with a market capitalisation of $40.80M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.62 to $12.80. This page covers its latest market performance, valuation, price trends and company information.
$40.80M | |
$1.79 | |
$12.80 | |
$1.62 | |
$1.78 | |
-- | |
52.33K | |
-- | |
$12.80 | |
$1.62 | |
-- | |
-- |
BioHarvest Sciences Inc. (BHST) is trading at $1.79 in pre-market trading as of 2026-09-16 08:02:00, up 1.07% ($0.02) from the previous close of $1.78
Pre-market trading shows how investors are pricing BHST before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.
Over the past seven days, BioHarvest Sciences Inc. (BHST) moved from $1.82 to $1.79, representing a decline of 1.43% ($0.03).
The stock traded between $1.62 and $2.05 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.
The average daily volume was 33.36 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 1.6%
BHST is currently trading at $1.79, placing it 1.6% of the way from its 52-week low of $1.62 to its 52-week high of $12.80. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. The Company has two operating segments or business units: the Products business unit and the CDMO Services business unit. In identifying these operating segments, management generally follows the Company's service lines representing its main products and services. The Products Business Unit - Nutraceuticals: Research, development, manufacturing, marketing and sales of science-based health and wellness nutraceutical solutions which are manufactured and sold as dietary supplements, functional food and beverages. The CDMO Services Business Unit - comprising a Contract Development and Manufacturing Operation that offers pharmaceuticals, cosmeceuticals, nutraceuticals, and nutritions.
| Employees | 89 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of BioHarvest Sciences Inc. (BHST) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.